DS-8273a
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DS-8273a, covering 2019-02-12 to 2019-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer [Phase 1]